insights_auto
Why is SCNI down 5.26%?
Dive Deeperchevron_right
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.26
arrow_downward
-5.26%(-0.070) 1D
$1.27
arrow_upward
+0.79% (+0.0100)bedtimeAfter hours
Closed: Oct 5, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.33
High
$1.36
Low
$1.26
Mkt. cap
718.23K
Avg. vol.
2.27M
Volume
0.00
52-wk high
$16.30
52-wk low
$1.26
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
Open
$1.33
High
$1.36
Low
$1.26
Mkt. cap
718.23K
Avg. vol.
2.27M
Volume
0.00
52-wk high
$16.30
52-wk low
$1.26
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
Simply Wall Street
·
28 minutes ago
Manufacturing Approval Could Change The Case For Alvotech (ALVO) Stock
TradingView
·
2 hours ago
NYSE Owner Starts Gold Futures in London, a Market Without One Since 2022
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR